Centene Corporation
CNC Healthcare Healthcare Plans
Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.92%, EPS grew 533.3%, free cash flow grew 116.6% and total debt fell 8.37%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.
Follow CNC
Centene Corporation (CNC) EBITDA
Centene Corporation's EBITDA for fiscal 2025 was −$6.3B, compared with $4.4B in fiscal 2024. Over the twelve months to 30 June 2026 it was −$4.4B. Over the past ten years it has ranged from −$6.3B (fiscal 2025) to $4.4B (fiscal 2024) — the current reading is the lowest in ten years. Centene Corporation ranks 12th of 12 Healthcare Plans companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | −$6.3B | — |
| FY2024 | $4.4B | 4.57% |
| FY2023 | $4.2B | 53.68% |
| FY2022 | $2.7B | (11.89%) |
| FY2021 | $3.1B | (28.15%) |
| FY2020 | $4.3B | 79.08% |
| FY2019 | $2.4B | 24.12% |
| FY2018 | $2.0B | 25.19% |
| FY2017 | $1.6B | 1.23% |
| FY2016 | $1.5B | 80.44% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $1.5B | (30.68%) |
| Mar 2026 | $2.2B | — |
| Dec 2025 | −$1.4B | — |
| Sep 2025 | −$6.6B | — |
| 42 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| UNH UnitedHealth Group Incorporated compare | $26.0B |
| CVS CVS Health Corporation compare | $18.5B |
| CI Cigna Group compare | $12.7B |
| ELV Elevance Health, Inc. compare | $8.8B |
| HUM Humana Inc. compare | $3.5B |
| OSCR Oscar Health, Inc. compare | $632.0M |
| MOH Molina Healthcare, Inc compare | $371.0M |
| CLOV Clover Health Investments, Corp. compare | −$18.2M |
| CNC Centene Corporation | −$4.4B |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on CNC
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement